OHSU illuminates opioid epidemic

Panel highlights need to reduce stigma and enhance treatment

By Erik Robinson November 13, 2017 Portland, Oregon

Downloads

OHSU Illuminate luncheon, November 8, 2017. (OHSU/Kristyna Wentz-Graff)

A panel discussion on fighting the opioid epidemic was the focus of the 2017 OHSU Illuminate luncheon, November 8, 2017. (OHSU/Kristyna Wentz-Graff)

OHSU Illuminate

(Left to right) Honora Englander, M.D., Dennis McCarty, Ph.D., Alisha Moreland-Capuia, M.D., and moderator Dwight Holton, J.D., participate in a panel discussion on opioids at the OHSU Illuminate luncheon, November 8, 2017. (OHSU/Kristyna Wentz-Graff)

OHSU Illuminate

Alisha Moreland-Capuia, M.D., participates in a panel discussion on opioids at the OHSU Illuminate luncheon, November 8, 2017. (OHSU/Kristyna Wentz-Graff)

OHSU Illuminate

Dwight Holton, J.D., moderates a discussion on the opioid epidemic at the OHSU Illuminate luncheon, November 8, 2017. (OHSU/Kristyna Wentz-Graff)

OHSU Illuminate

Honora Englander, M.D., and Dennis McCarty, Ph.D., participate in a panel discussion on opioids at the OHSU Illuminate luncheon, November 8, 2017. (OHSU/Kristyna Wentz-Graff)

OHSU Illuminate

Honora Englander, M.D., participates in a panel discussion on opioids at the OHSU Illuminate luncheon, November 8, 2017. (OHSU/Kristyna Wentz-Graff)

OHSU Illuminate

Dennis McCarty, Ph.D., participates in a panel discussion on opioids at the OHSU Illuminate luncheon, November 8, 2017. (OHSU/Kristyna Wentz-Graff)

OHSU Illuminate

OHSU Illuminate luncheon, November 8, 2017. (OHSU/Kristyna Wentz-Graff)